Molecules 2013, 18(1), 757-767; doi:10.3390/molecules18010757
Article

In Vitro and in Vivo Anticancer Activity of Aconitine on Melanoma Cell Line B16

1,†, 1,†, 2, 1, 1, 1 and 1,* email
Received: 11 November 2012; in revised form: 29 November 2012 / Accepted: 5 January 2013 / Published: 8 January 2013
Download PDF [1035 KB, updated 18 June 2014; original version uploaded 18 June 2014]
Abstract: The anti-tumor effect of aconitine in melanoma cell line B16 has been studied in this paper. We found that B16 cells showed significantly reduced growth rates and increased apoptotic effects in the presence of aconitine. Furthermore, aconitine inhibited the PI3K/AKT and MAPK/ERK1/2 signaling pathways, thus regulating the levels of protein and mRNA of PCNA and apoptotic related signaling molecules. Above all, we found that aconitine showed an anti-melanoma effect in suppressing tumor growth in vivo. In conclusion, we show that aconitine may be a useful anticancer drug in the future.
Keywords: melanoma; B16; aconitine; apoptosis; PI3K/AKT; MAPK/ERK1/2
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Du, J.; Lu, X.; Long, Z.; Zhang, Z.; Zhu, X.; Yang, Y.; Xu, J. In Vitro and in Vivo Anticancer Activity of Aconitine on Melanoma Cell Line B16. Molecules 2013, 18, 757-767.

AMA Style

Du J, Lu X, Long Z, Zhang Z, Zhu X, Yang Y, Xu J. In Vitro and in Vivo Anticancer Activity of Aconitine on Melanoma Cell Line B16. Molecules. 2013; 18(1):757-767.

Chicago/Turabian Style

Du, Juan; Lu, Xiaonian; Long, Ziwen; Zhang, Zhen; Zhu, Xiaohua; Yang, Yongsheng; Xu, Jinhua. 2013. "In Vitro and in Vivo Anticancer Activity of Aconitine on Melanoma Cell Line B16." Molecules 18, no. 1: 757-767.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert